Identification of an Indazole-Based Pharmacophore for the Inhibition of FGFR Kinases Using Fragment-Led de Novo Design

Turner, LD, Summers, AJ, Johnson, LO et al. (2 more authors) (2017) Identification of an Indazole-Based Pharmacophore for the Inhibition of FGFR Kinases Using Fragment-Led de Novo Design. ACS Medicinal Chemistry Letters, 8 (12). pp. 1264-1268. ISSN 1948-5875

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2017, American Chemical Society. This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Medicinal Chemistry Letters, copyright (c) American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see: https://doi.org/10.1021/acsmedchemlett.7b00349
Keywords: de novo; FGFR; fragment; indazole; SBDD
Dates:
  • Published: 14 December 2017
  • Accepted: 10 November 2017
  • Published (online): 11 November 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Maths and Physical Sciences (Leeds) > School of Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Jan 2018 16:52
Last Modified: 11 Nov 2018 01:39
Status: Published
Publisher: American Chemical Society
Identification Number: https://doi.org/10.1021/acsmedchemlett.7b00349

Share / Export

Statistics